GE, Eli Lilly, Celgene Partner with NYC, Launch Biotech Fund
The New York City Economic Development Corporation has partnered with Celgene, GE Ventures and Eli Lilly to create a biotech fund called the Life Sciences Funding Initiative.
The city will put in $50 million and says by leveraging at least that amount in matching funds, the partnership will deploy a minimum of $100 million and seek to launch 15 to 20 biotech ventures by 2020.
NYCEDC says a selection process is underway to identify the initiative’s anchor venture capital partners, which will be selected by the city. The city will make its selections in early 2014 and expects the Life Sciences Funding Initiative to make its first investments in mid-2014.
Earlier this year the SUNY College of Nanoscale Science and Engineering (CNSE) acquired the landmark Kiernan Plaza in downtown Albany, NY, in a bid to create a hub for smart cities technology companies. The $30-million CNSE-led initiative, identified as a priority project by Gov. Andrew M. Cuomo’s Capital Region Economic Development Council (CREDC), will position New York as a global leader in this high-tech industry, Cuomo says.
Energy Manager News
- Atlantic City Electric Rate Increase Settled; PowerAhead Funding Deferred to Phase II
- TVA Reduces Budget Requirements and Continues Investing in Cleaner Power
- Commercial Refrigeration Benefits from Efficiency and Environmental Efforts
- TechNavio Releases Commercial AC Report
- Dubuque Meeting Hears About Energy Audits
- Science-Based Targets Inspire a Smarter Investment Strategy in Retail
- Missouri Lawmakers Resume Debate on Utility Rate Hikes
- Wake Forest Drops Its Residential and C&I Electric Rates